Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Opens Molecular Biology Center of Excellence in Lithuania

Published: Friday, September 21, 2012
Last Updated: Friday, September 21, 2012
Bookmark and Share
New facility expands R&D and manufacturing capabilities in eastern Europe for molecular, protein and cellular biology products.

Thermo Fisher Scientific Inc. has announced the official opening of its Molecular Biology Center of Excellence in Vilnius, Lithuania.

The new facility will provide molecular, protein and cellular biology products to better serve growing demand from life sciences customers throughout Eastern Europe, and create new opportunities globally.

Since acquiring Vilnius-based Fermentas International Inc. in 2010, Thermo Fisher has continued to invest in the region to capitalize on its base of world-class educational institutions and scientific research talent.

The Vilnius site will showcase world-class capabilities for developing and manufacturing products used in a range of life sciences applications.

For example, it provides innovative technologies for PCR-based (polymerase chain reaction) testing, nucleic acid sample preparation protein purification and antibodies for ELISA (enzyme-linked immunosorbent assay) testing.

“Our expanded R&D and manufacturing presence in Vilnius strengthens our ability to serve the growing biotechnology community in Eastern Europe, particularly our research customers who rely on innovations in molecular biology to accelerate developments in diagnosing and treating disease,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific.

Casper continued, “We now have a solid foundation from which we can continue to increase our depth of capabilities for high-growth life sciences markets in the region, from PCR-based products to our broader biosciences portfolio.”

The 156,000-square-foot Molecular Biology Center of Excellence is currently home to more than 400 research, laboratory and manufacturing personnel, with room for expansion.

In addition to its geographically central location, Lithuania is known for its well-established commitment to innovation, highly skilled life sciences workforce and favorable economic environment.

As part of Thermo Fisher’s investment in developing the scientific workforce in Lithuania, the company has collaborated with the University of Vilnius to construct a mobile biology laboratory for high school students that provides hands-on experience with molecular biology and DNA experimentation.

Thermo Fisher also supports science education in Lithuania through a series of initiatives, including internships and scholarships that provide students with practical experience and financial support.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific and bioMérieux Renew Partnership
The companies have renewed their non-exclusive, long-term, royalty-bearing agreement for Procalcitonin testing.
Wednesday, October 03, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!